Influenza vaccination coverage among children with high-risk medical conditions

Susanna Esposito1, Paola Marchisio, Roberta Droghetti

  • 1Institute of Pediatrics, University of Milan, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Via Commenda 9, 20122 Milano, Italy.

Vaccine
|April 20, 2006
PubMed

Insights

Influenza vaccination coverage in high-risk children improved but remains inadequate. Increased knowledge among parents and pediatricians is crucial for better prevention of influenza complications in these vulnerable children.

Area of Science:

  • Pediatrics
  • Immunology
  • Public Health

Background:

  • Influenza poses significant risks to children with chronic diseases.
  • Low vaccination rates have historically been observed in this high-risk pediatric population.
  • Understanding parental and pediatrician knowledge is key to improving influenza prevention.

Purpose of the Study:

  • To assess influenza vaccination coverage in high-risk children.
  • To identify gaps in knowledge regarding influenza and its prevention among parents and pediatricians.
  • To highlight the need for improved strategies to increase vaccination rates.

Main Methods:

  • Retrospective analysis of vaccination data for children under 14 years old attending an Emergency Department.
  • Inclusion of 274 high-risk patients identified from a total of 5286 children.
  • Evaluation of vaccination trends over three influenza seasons (2000-2003).

Main Results:

  • Influenza vaccination coverage significantly increased from 5.1% in 2000-2001 to 26.3% in 2002-2003 (p<0.001).
  • Children with asthma or cardiac disease exhibited the lowest vaccination rates.
  • Parents and primary care pediatricians demonstrated limited knowledge of influenza prevention benefits.

Conclusions:

  • Current influenza vaccine delivery to high-risk children is insufficient.
  • Substantial efforts are required to enhance awareness among parents and pediatricians about influenza prevention.
  • Targeted educational interventions are necessary to improve vaccination uptake in this vulnerable group.

Related Concept Videos

Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Vaccinations01:51

Vaccinations

Overview
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.